Sort by 'likes'
Everything you need to know about Daratumumab and Multiple Myeloma
FDA recently approved daratumumab (Darzalex) to treat patients with multiple myeloma who have received atleast three prior treatments. Daratumumab is the first monoclonal antibody approved for treating myeloma and provides another treatment option for patients who have become resistant to…
Reversing Blindness with New FDA Approved Retinal Gene Therapy
In December 2017, the FDA approved a DNA altering medication that can reverse an inherited form of progressive blindness. Luxturna is a gene therapy which can treat a condition called Leber's Congenital Amaurosis (LCA) wherein people have inherited two faulty…
Polycystic Ovary Syndrome (PCOS) & It’s Relationship to Metabolic Risk Factors (Obesity, Diabetes, Hair growth and more)
Polycystic ovary syndrome (PCOS) is a health condition that affects 1 in 10 women of childbearing age. Women with PCOS have a hormonal imbalance and metabolism problems that may lead to obesity, cardiovascular disease, type 2 diabetes, infertility, endometrial cancer…
Discussing Myeloma Clinical Trials with Dr.Chari from Mount Sinai
Dr. Ajai-Chari from Mount Sinai Hospital, New York, a renowned myeloma expert, discusses Clinical Trials related to myeloma.
Alzheimer’s or Dementia. What’s the Difference?
Over 10 million people in the US have a neurodegenerative condition. Half of these people have Alzheimer's Disease making it the most common neurodegenerative condition in the US. Among the remaining, a large population suffer from frontotemporal dementia (FTD). However,…